Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

CORRONA Team Provides Data-Based Tool to Address Rheumatology’s Questions

Gretchen Henkel  |  Issue: December 2012  |  December 1, 2012

J. Timothy (Tim) Harrington, MD, a rheumatologist at UW Health, the academic health system for the University of Wisconsin in Madison, became interested in CORRONA “because of the ability to create a ‘laboratory’ for testing standardized data management and its impacts on care and disease outcomes,” he says. His collaborations with Dr. Kremer had their start in 2000 with a discussion during a continuing medical education course in Whistler, B.C. “We shared our dreams,” Dr. Harrington recalls. “His was to build an RA observational registry, which has become CORRONA, and mine was to improve and redesign rheumatology practice in the United States—both rather humble goals,” he quips.

Since that time, Dr. Harrington, a noted quality-improvement researcher and author, has become chief site quality officer for CORRONA. In that capacity, he has overseen refinement of the data questionnaire and incorporation of several practice efficiency elements, such as the Physician Quality and Reporting System and Meaningful Use, into the CORRONA registry for participating practices. He was also the first to do a pilot study implementing the CORRONA data set, and found that by using its standardized data set, he was able to decrease by 40% the amount of time he spent taking the patient’s history and documenting encounters in the medical record. “I used to spend 70% of my time finding out what’s going on with the patient and 30% doing something about it. Now I spend 30% of my finding out what’s going on and 70% of my time doing something about it!” Dr. Harrington says. This process has implications for dealing with workforce issues as well, he notes. “If you standardize the data process within your practice, then you can start to move major amounts of work for coordinating patient care, assessing disease status, and treatment safety from the physician visit into the nurse or [nurse practitioner] encounter,” he maintained. [For more on practice redesign, read “High-Impact Rheumatology Practice Redesign” at www.The-Rheumatologist.org.]

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“The CORRONA Virus”

At the outset, Dr. Kremer says, “I insisted on two themes. One was to work with and empower good people, and the other was to be inclusive. We have a horizontal structure, not a vertical one, and that has allowed an environment of mutual respect.” He rejoices about the high level of talent the database has attracted. The company now has a staff of 35 employees, including Chief Operating Officer James Cavan, MS, crack information-technology and project-management teams, and an experienced epidemiological and biostatistician cadre, as well as legal and other support staff.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsGout and Crystalline ArthritisInformation TechnologyPractice SupportProfilesPsoriatic ArthritisQuality Assurance/ImprovementResearch RheumRheumatoid ArthritisTechnologyTechnology Tagged with:Goutpatient carepatient registryProfilePsoriatic ArthritisResearchRheumatoid arthritisrheumatologistTechnologyTreatment

Related Articles

    CORRONA: History & Lessons Learned

    December 9, 2022

    Editor’s note: In November, the ACR honored Joel M. Kremer, MD, MACR, president of the Corrona Research Foundation, with its Distinguished Clinical Investi­gator Award for his outstanding contributions to the field of rheumatology as a clinical scientist (see story here). As the founder of the Consortium of Rheumatology Researchers of North America (CORRONA, now known…

    Janus Kinase Inhibitors Represent New Tool to Slow Rheumatoid Arthritis

    July 1, 2014

    Physicians at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco report on studies about JAK inhibitors as targeted immunomodulators and disease-modifying therapies in RA

    The 2022 ACR Awards of Distinction

    December 8, 2022

    During ACR Convergence 2022 in early November, the ACR honored a group of individuals who have made significant contributions to rheumatology research, education and patient care by announcing the recipients of the ACR’s 2022 Awards of Distinction, as well as the 2022 ACR Masters, recognized for their contributions to the field. See the November issue…

    ACR Winter Rheumatology Symposium: Answers to Your Tough Questions about Rheumatic Disease Therapy

    May 1, 2013

    Panelists discuss vaccination, biologics and infection, methotrexate, cardiovascular risk, and serial immunoglobulin testing and imaging

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences